Related Experiment Videos
[Malignant lymphomas of soft tissues]
1Institut für Pathologie, Städt, Krankenhaus München-Harlaching.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie
|January 1, 1992
Summary
Malignant lymphoma presenting as soft tissue tumors is rare, accounting for 1.2-2% of cases. Diagnosis requires careful consideration alongside other sarcomas and carcinomas, aided by cell markers.
Area of Science:
- Oncology
- Pathology
- Hematology
Background:
- Malignant lymphomas are rarely identified as primary soft tissue tumors, representing 1.2% to 2% of annual soft tissue tumor consultations.
- Their presentation necessitates inclusion in the differential diagnosis for various soft tissue lesions, including round cell sarcomas, undifferentiated carcinomas, and myxoid spindle cell sarcomas.
Observation:
- Immunohistochemical analysis using pan-leukocyte and B-/T-cell markers is crucial for accurate differential diagnosis.
- All identified cases were non-Hodgkin lymphomas, predominantly of the B-cell type, characterized by large cells (centroblasts per Kiel classification).
Findings:
- The study observed a predominance of large B-cell non-Hodgkin lymphomas among soft tissue malignant lymphomas, consistent with limited published series.
- Despite a 'highly malignant' morphology, these lymphomas exhibited a relatively good prognosis.
- A notable characteristic was their propensity for soft tissue involvement, even post-dissemination.
Implications:
- Further research into specific phenotypic and genotypic cellular findings is warranted for malignant lymphomas presenting as soft tissue tumors.
- This could enhance diagnostic accuracy and potentially refine treatment strategies for this rare entity.
- Understanding these specific cellular characteristics may parallel insights gained from studies on subcutaneous T-cell lymphoma and primary bone lymphoma.